Tury, S., Becette, V., Assayag, F., Vacher, S., Benoist, C., Kamal, M., . . . Callens, C. (2016). Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer. Oncotarget.
シカゴスタイル引用形Tury, Sandrine, et al. "Combination of COX-2 Expression and PIK3CA Mutation As Prognostic and Predictive Markers for Celecoxib Treatment in Breast Cancer." Oncotarget 2016.
MLA引用形式Tury, Sandrine, et al. "Combination of COX-2 Expression and PIK3CA Mutation As Prognostic and Predictive Markers for Celecoxib Treatment in Breast Cancer." Oncotarget 2016.
警告: この引用は必ずしも正確ではありません.